SHAREHOLDER ALERT: The M&A Class Action Firm Encourages Stockholders of EMKR, CCRN, WMPN, ALVR to Act Now
Nyenta.com/10303838

NEW YORK, Feb. 12, 2025 ~ New York City - Monteverde & Associates PC, a leading class action firm, has recently announced their recovery of millions of dollars for shareholders and their recognition as a Top 50 Firm by ISS Securities Class Action Services Report. Headquartered at the iconic Empire State Building, the M&A Class Action Firm is currently investigating several cases.

One of the cases being investigated is that of EMCORE Corporation (NASDAQ: EMKR), in relation to its proposed merger with Velocity One Holdings, LP. According to the terms of the agreement, EMCORE stockholders will receive $3.10 per share of EMCORE common stock they own. The Shareholder Vote for this case is scheduled for February 27, 2025.

Another case being looked into is that of Cross Country Healthcare, Inc. (NASDAQ: CCRN), which involves a proposed merger with Aya Healthcare. Under the terms of the agreement, shares of Cross Country will be converted into the right to receive $18.61 in cash. The Shareholder Vote for this case is set for February 28, 2025.

William Penn Bancorporation (Nasdaq: WMPN) is also under investigation for its proposed merger with Mid Penn Bancorp, Inc. As per the agreement, shareholders of William Penn will receive 0.4260 shares of Mid Penn common stock for each share of William Penn common stock they own. Additionally, all options of William Penn will be rolled into Mid Penn equivalent options. The implied transaction value is approximately $13.58 per William Penn share. The Shareholder Vote for this case is scheduled for April 2, 2025.

More on Nyenta.com

• Acmeware and Avo Partner to Bring Real-Time Data Integration to MEDITECH Customers
• CCHR Says Mounting Evidence of Persistent Sexual Dysfunction From Antidepressants Demands FDA Action
• How Truck Dispatch Services Help Owner-Operators Increase Weekly Profits
• Members Heritage Credit Union Taps Scienaptic AI to Power Frictionless, Inclusive Credit Decisions and Transform Lending
• Rigani Press Announces Ebook Version Now Available for RUSHING HEADLONG by S. Yin Ho

Lastly, AlloVir, Inc. (Nasdaq: ALVR) is being investigated in relation to its proposed merger with Kalaris Therapeutics. Under the terms of the agreement, AlloVir will acquire 100% of the outstanding equity interest of Kalaris. Upon completion, pre-Merger AlloVir stockholders are expected to own approximately 25.05% of the combined company. The Shareholder Vote for this case is set for March 12, 2025.

Monteverde & Associates PC is urging shareholders to act now and participate in these cases. They have provided links for more information on each case, which are free and do not require any cost or obligation.

Before hiring a law firm, it is important to ask the right questions. Monteverde & Associates PC advises shareholders to inquire about the firm's experience in filing class actions and going to court, as well as their track record of recovering money for shareholders and details of previous successful cases.

It is evident that not all law firms are the same, and it is crucial for shareholders to choose a reputable and experienced firm when seeking legal representation. With their impressive track record and recognition as a Top 50 Firm by ISS Securities Class Action Services Report, Monteverde & Associates PC stands out as a reliable option for shareholders seeking justice.

---

Show All News | Report Violation